Form 4: Northrop Grumman Executive Reports Stock Transactions
Insider Transaction Report
A Northrop Grumman Corp. executive reported the vesting of restricted stock rights and subsequent sales of common stock.
Summary
- Michael A. Hardesty, Corporate VP, Controller & CAO of Northrop Grumman Corp., reported transactions on February 17, 2026.
- 538 shares of common stock were acquired at a price of $0.00 upon the vesting of Restricted Stock Rights (RSRs).
- 243 shares of common stock were disposed of at $701.12 per share, likely for tax withholding related to the RSR vesting.
- An additional 715.94 shares of common stock were sold at $700.63 per share.
- Following these transactions, Michael A. Hardesty beneficially owns 2,672.29 shares of common stock.
- The executive also holds 1,494 Restricted Stock Rights (RSRs) that are yet to vest, with future vesting dates in 2027, 2028, and 2029.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-slightly positive event. The vesting of RSRs is a positive for the executive, while the subsequent sales are routine for tax purposes and personal liquidity, not indicative of a negative outlook on the company.
Positives
- The vesting of 538 Restricted Stock Rights (RSRs) into common stock represents a realization of long-term incentive compensation for the executive.
- The executive continues to hold a significant number of unvested RSRs (1,494), indicating ongoing alignment with shareholder interests.
Negatives
- The disposal of 715.94 shares of common stock represents a reduction in the executive's direct equity holdings in the company.
Future Outlook
The filing indicates future vesting events for Michael A. Hardesty's Restricted Stock Rights on February 16, 2027, February 18, 2028, and February 12, 2029, suggesting continued long-term incentive alignment.
Industry Context
StockSavvy.ai notes that routine insider transactions, such as those involving the vesting of equity awards and subsequent sales for tax purposes or portfolio rebalancing, are common across all industries, including the defense sector where Northrop Grumman operates. These transactions typically reflect pre-planned compensation structures rather than new strategic insights.
Stakeholder Impact
- Shareholders: The transactions represent routine insider activity and do not suggest a significant change in company fundamentals or strategy. The executive's continued holding of unvested RSRs maintains alignment with long-term shareholder value.
Next Steps
- 554 Restricted Stock Rights are scheduled to vest on February 16, 2027.
- 561 Restricted Stock Rights are scheduled to vest on February 18, 2028.
- 379 Restricted Stock Rights are scheduled to vest on February 12, 2029.
Key Dates
| Date | Description |
|---|---|
| 02/16/2023 | Grant date of Restricted Stock Rights (RSRs) under the 2011 Long-Term Incentive Stock Plan (LTISP) that vested on 02/17/2026. |
| 02/14/2024 | Grant date of 554 RSRs under the 2011 LTISP, which will vest on 02/16/2027. |
| 02/18/2025 | Grant date of 561 RSRs under the 2024 LTISP, which will vest on 02/18/2028. |
| 02/11/2026 | Grant date of 379 RSRs under the 2024 LTISP, which will vest on 02/12/2029. |
| 02/17/2026 | Date of earliest transaction, including RSR vesting, tax withholding, and common stock sale. |
| 02/19/2026 | Signature date of the Form 4 filing. |
| 02/16/2027 | Vesting date for 554 RSRs granted on 02/14/2024. |
| 02/18/2028 | Vesting date for 561 RSRs granted on 02/18/2025. |
| 02/12/2029 | Vesting date for 379 RSRs granted on 02/11/2026. |
Recommendation
holdThis Form 4 filing details routine insider transactions related to executive compensation and pre-planned sales. It does not provide new material information about Northrop Grumman's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and do not signal a shift in the executive's confidence in the company.
Keywords
Northrop Grumman, NOC, Insider Trading, Form 4, Stock Transaction, Restricted Stock Rights, Executive Compensation, Stock Sale, Defense Industry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.